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Normal Wound Healing in Mice Deficient for
Fibulin-5, an Elastin Binding Protein Essential for
Dermal Elastic Fiber Assembly
Qian Zheng1, Jiwon Choi2, Leonie Rouleau3, Richard L. Leask3, James A. Richardson1,4, Elaine C. Davis2 and
Hiromi Yanagisawa1
Extracellular matrix proteins play a critical role in dermal wound healing by mediating matrix–cell interactions
and re-establishing the dermal architecture and environment. Fibulin-5 is an elastin-binding protein essential
for elastic fiber development in vivo, and it has recently been shown to inhibit angiogenesis in vitro. Here, we
use mice deficient for the fibulin-5 gene (fbln5) to examine the role of fibulin-5 and the effect of the loss of
elastic fibers in dermal wound healing. Fbln5 is upregulated in the granulation tissue 14 days after full-thickness
wounding in wild-type mice, before the formation of elastic fibers. Although wounded fbln5/ skin showed
enhanced neovascularization compared to the wild-type skin, no difference in the rate of wound closure was
observed between mutant and wild-type mice. In addition, a breaking strength test revealed that there was no
difference in breaking stress or strain between wild-type and fbln5/ wounded skin. These results suggest that
fibulin-5 and elastic fibers are not directly involved in short-term wound healing. Clearly, the long-term effect of
the absence of fibulin-5 on the function and integrity of regenerated skin needs to be further addressed.
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INTRODUCTION
Dermal wound healing is a coordinated process of tissue
remodeling involving an inflammatory response, re-epithe-
lialization, and revascularization (reviewed in Singer and
Clark 1999). The process is mediated by soluble cytokines
and growth factors, which act on multiple cell types
including keratinocytes, dermal fibroblasts, and vascular
cells. Activated inflammatory cells secrete various matrix
proteinases to facilitate breakdown of the extracellular matrix
(ECM), which aids in the migration of keratinocytes and
fibroblasts into the wound bed (Parks, 1999; Midwood et al.,
2004). Deposition of provisional matrices such as fibronectin
provides a permissive environment for angiogenesis to occur,
which ultimately leads to the healing of the wound and
restoration of dermal function.
Collagen and elastic fibers are important components of
the dermal ECM and are essential for the maintenance of skin
integrity. Skin substitutes containing ECM such as acellular
collagen and glycosaminoglycan matrices are routinely used
for treatment of acute burns as an alternative to autografting
and allografting (Horch et al., 2005). Recent histological
analysis, however, has shown that the skin regenerated after
using these dressings fails to form adnexal structures and
elastic fibers (Moiemen et al., 2001). In another study,
epidermal transplantation and dermal matrix substitutes
containing both collagen and elastin reduced wound
contraction and improved tissue regeneration (Lamme
et al., 1996). In order to improve the efficacy of synthetic
skin or skin equivalents, the role of each ECM component
produced during wound healing needs to be evaluated.
Fibulin-5 is an elastin-binding protein essential for elastic
fiber development in vivo (Nakamura et al., 2002; Yanagi-
sawa et al., 2002). Various elastogenic cells such as dermal
fibroblasts, lung fibroblasts, and vascular smooth muscle cells
secrete fibulin-5 and are responsible for tissue-specific
elastogenesis. Recently, retrovirus overexpressing fbln5 was
shown to promote wound healing in a full-thickness wound
made in rabbit ear by inducing the formation of granulation
tissue and remodeling the ECM (Lee et al., 2004). It is not
clear, however, whether this effect was owing to an increase
in elastic fiber assembly in the wound bed or whether it was
mediated through other biological properties of fibulin-5.
For instances, fibulin-5 has been shown to antagonize angio-
genesis in vitro by binding to vascular endothelial growth
factor and suppressing downstream signaling (Albig and
Schiemann, 2004). Overexpression of fbln5 can also
suppress increased proliferation and migration of fbln5/
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vascular smooth muscle cells by a yet unknown mechanism
(Spencer et al., 2005). Furthermore, fibulin-5 can bind cell
surface integrins via an RGD (arginine-glycine-aspartic acid)
motif located in the first calcium binding epidermal growth
factor (CB-EGF)-like domain (Nakamura et al., 1999). Thus, it
is possible that some of the biological effects of fibulin-5 may
be related to integrin binding and signaling.
In the present study, we examined whether the absence of
fibulin-5 and the presence of abnormal elastic fibers in
fbln5/ mouse skin would impact wound closure in vivo, or
alternatively, whether fibulin-5 plays a key role in dermal
wound healing by affecting the properties of dermal cells.
RESULTS
Fibulin-5 is upregulated during wound healing
We first examined the expression of fbln5 during wound
healing in wild-type mice by reverse transcriptase-PCR. RNA
was prepared from the dorsal skin before and after full-
thickness excision wounding. As shown in Figure 1a, adult
skin expressed a low level of fbln5 and the expression was
significantly upregulated at day 14. Immunostaining for
fibulin-5 showed that the upper dermis, perifollicular region,
and the blood vessel walls of small arteries (data not shown)
were positive for fibulin-5 in non-wounded skin (Figure 1b).
Fourteen days after wounding, granulation tissue forming the
wound bed, including newly formed vessels, was intensely
stained with fibulin-5 (Figure 1d and f). The regenerative
hyperplastic epidermis was also positive for fibulin-5 (Figure
1f). On adjacent sections, elastin immunoreactivity was
unchanged (data not shown). Control sections from fbln5/
mice showed no staining for fibulin-5, although the part of
epidermis gave a false-positive reaction (Figure 1c, e, and g).
These data indicated that fibulin-5 is upregulated in the gran-
ulation tissues during the subacute phase of wound healing.
Wound closure was not affected in fbln5/ mice
In previous work, we observed an exacerbated vascular
injury response in fbln5/ mice following flow cessation-
induced injury to the carotid artery (Spencer et al., 2005). We
therefore wanted to determine whether the compromised
elastic fibers in fbln5/ mice would affect wound healing in
vivo, and whether the absence of fibulin-5 would increase
migration and proliferation of vascular cells and fibroblasts
into the wound bed. Fbln5/ and wild-type littermates were
subjected to full-thickness excision wounding in the dorsal
skin and wound healing was photographed on the days
indicated (Figure 2a). At six different time points, the area of
the wound was measured and expressed as a percentage of
the initial wound size (Figure 2b). No statistical difference
was found at any time point between wild-type and fbln5/
mice and wounds from both genotypes were closed by day
14. Macroscopically, we observed excessive skin folds
running in multiple directions in fbln5/ mice compared
to wild-type mice (see Figure 2a, day 14). Upon histological
examination, both wild-type and fbln5/ skin showed re-
epithelialization and dermal fibrosis (Figure 2c and f). No
difference was detected in the distribution or intensity of
collagen fibers (Figure 2d and g). Elastin staining revealed that
elastic fibers had not yet regenerated in the wound bed of
wild-type skin, whereas dense elastic fibers were observed in
non-injured dermis adjacent to the wound (Figure 2e,
arrows). In fbln5/ mice, no filamentous network of elastic
fibers was seen in the dermis within or outside of wound bed
(Figure 2h). These data indicate that absence of fibulin-5 does
not positively or negatively affect wound closure in vivo.
Fibulin-5 does not affect migration or proliferation of dermal
cells in vitro
In order to examine if fibulin-5 affects dermal cell function,
primary skin fibroblasts from newborn wild-type and fbln5/
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Figure 1. Fibulin-5 expression and localization during skin excision wound
healing. (a) Upregulation of fbln5 during dermal wound healing. Reverse
transcriptase-polymerase chain reaction was performed using RNA prepared
from the dorsal skin harvested before (day 0) and after (days 3 and 14)
full-thickness excision wounding in wild-type mice. Glycerol-3-phosphate
dehydrogenase was used as internal control. There was no consistent increase
in fbln5 expression at early phase of wound healing, whereas the significant
upregulation was observed at 14 days. (b–g) Detection of fibulin-5 by
immunohistochemistry. Sections of adult dorsal skin were stained with anti-
fibulin-5 antibody before (b, c) or 14 days post-wounding (d–g) in wild-type
(WT; b, d, f) and fbln5/ (KO; c, e, g) mice. Fibulin-5 was expressed around
hair follicles, and to a lesser extent in the upper dermis before wounding
(b, arrows). After wounding, robust fibulin-5 immunoreactivity was detected
in the granulation tissue in the wild-type mouse (d, f, asterisks). Similar areas
were not stained in fbln5/ skin (c, arrows; e, g, asterisks). Regenerated
epidermis (f, arrow) expressed fibulin-5. Dotted line separates wounded
and surrounding dermis. Bar¼200 mm.
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pups were isolated and the effect of fibulin-5 on proliferation
and migration was assessed. After synchronization, cells were
stimulated with EGF (10 ng/ml) for 24 hours and cell number
was assessed by colormetric assay. No difference in proli-
ferative response to EGF between wild-type and fbln5/
cells was seen (Figure 3a). Scratch assays performed in the
presence of EGF showed a modest increase in migratory
response in wild-type and fbln5/ cells over control
cultures. Stimulation with 20% fetal bovine serum (FBS)
induced a strong migratory response; however, no significant
difference was observed between cells from the two
genotypes (Figure 3b). Western analysis demonstrated similar
activation of downstream signaling pathways involving
phosphorylated extracellular signal-regulated kinase1/2, c-Jun
N-terminal kinase, and focal adhesion kinase (Figure 3c), and
stimulation with platelet-derived growth factor (20 ng/ml)
showed the same results as with serum (data not shown).
Similar results were obtained using mouse embryonic
fibroblasts (data not shown).
We next examined the potential of skin keratinocytes to
epithelialize using a skin ex vivo assay. Outgrowth of
keratinocytes from the skin explants was evaluated after 5
days and keratinocytes were stained with an anticytokeratin
antibody (Figure 3d). Total migration area showed no
difference between wild-type and fbln5/ explants, consis-
tent with our in vivo data (Figure 3e).
Dermal tensile strength
To determine if the biomechanical function of the wound bed
was maintained in fbln5/ mice, breaking strength testing
was performed using dorsal skin harvested 14 days after
incision wounding. No difference was observed in incisional
wound closure between wild-type and fbln5/ mice (data
not shown). There was also no significant difference in skin
thickness between wild-type and fbln5/ mice; however, the
skin from the wounds was significantly thicker than the
contralateral unwounded control skin in both groups
(compare Figure 4c and f). The skin was subjected to uniaxial
extension, in which the force was applied perpendicular to
the wound. The average breaking stress in unwounded wild-
type skin was lower than fbln5/ skin; however, this was not
statistically significant (P¼ 0.55, unpaired t-test; Figure 4a).
The mean strain at breaking was also similar (Figure 4b). The
breaking stress was reduced by an order of magnitude upon
wounding in both the wild-type and fbln5/ mice (Figure
4d). The breaking strain was similarly reduced, but not signi-
ficantly different for both wounded wild-type and fbln5/
mouse skin (Figure 4d and e). These data indicated that the
breaking strength of wounded skin was not affected by the
absence of fibulin-5.
Increased angiogenesis did not facilitate wound closure in
fbln5/ mice
Neovascularization is an important component of wound
healing, and conditions with impaired angiogenesis, such as
diabetes, are known to cause a delay in healing (Falanga,
2005). In previously reported work, we established that
fibulin-5 is an inhibitory matrix to vascular smooth muscle
cells (Spencer et al., 2005). It was of interest, therefore, to
determine if the absence of fibulin-5 would result in an
accelerated or increased vascular response in the wound bed.
We first performed CD31 immunostaining on sections of non-
injured skin from wild-type and fbln5/ mice. As seen in
Figure 5(a–d), an increased number of CD31-positive dermal
vessels were observed in fbln5/ skin, with vessels that were
wider and more tortuous compared to those in wild-type
dermis. The same result was obtained using a-smooth muscle
actin immunostaining (data not shown), indicating that there
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Figure 2. Macroscopic and histological observations of wound closure.
(a) Representative photographs showing the wounds in wild-type (WT) and
fbln5/ mice at indicated time after wounding. Note increased skin folds in a
random direction in the fbln5/ mouse (arrows) at day 14 compared to the
wild-type mouse (arrowhead). (b) Quantification of wound closure. Wound
areas were measured on days 1, 3, 5, 7, 10, and 14 after wounding and
expressed as percentage of the initial wound size (day 0). No statistically
significant difference was observed at any time point (P40.05). Open squares
indicate the wild-type (n¼ 7) and closed squares indicate fbln5/ mice
(n¼7). Bars indicate means7SD. (c–h) Histological examination of the
wild-type and fbln5/ skin 14 days after wounding. (c, f) Hematoxylin and
eosin staining shows granulation tissues (g) devoid of hair follicles and
overlying regenerated epidermis (re). No difference is evident between
wild-type (c) and fbln5/ mice (f). (d, g) Masson-Trichrome staining for
collagen fibers appears similar between the two genotypes. (e, h) Hart’s
staining for elastic fibers shows a network of elastic fibers in the dermis
adjacent to the wound in the wild-type skin (e, arrows), which is not seen in
the fbln5/ skin (h). No elastic fibers are formed in the granulation tissue in
either animal (g). Dotted lines indicate the border between the wound and
adjacent dermis. Bar¼ 400mm (c, d, f, g) and 200mm (e, h).
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was increased angiogenesis owing to the absence of fibulin-5
during embryonic and/or postnatal development. This result
is consistent with our macroscopic observation of an
increased number of vascular branches sprouting from the
long thoracic artery in the skin of fbln5/ mice compared to
wild-type mice (Sullivan et al., manuscript in preparation).
Fourteen days after injury, increased angiogenesis was
observed in both wild-type and fbln5/ dermis compared
to non-injured skin (Figure 5a–d). The total number of vessels
formed in response to wounding, however, was significantly
higher in fbln5/ skin compared to the wild-type skin (Figure
5e). Interestingly, we did not detect any difference in the
expression level of vascular endothelial growth factor iso-
forms, angiopoietin 1 and 2, or cardiac ankyrin repeat
protein, which has been implicated in the induction of
angiogenesis (data not shown) (Shi et al., 2005) in the
wounded bed. Overall, these results suggest that a fibulin5-
deficient microenvironment may be more permissive to
angiogenesis.
DISCUSSION
Fbln5 knockout mice were used to address the role of fibulin-
5 and elastic fibers in dermal wound healing. We also tested
whether a loss of fibulin-5 attenuates or exacerbates the
dermal injury response by acting on dermal cells and/or
vascular cells. Our present data showed that the absence of
fibulin-5 and an underlying elastic fiber defect does not affect
short-term wound closure or tensile strength of the wounded
skin. These results indicate that fibulin-5 does not play a
critical role in the wound healing process.
Dermal elastic fibers and wound healing
Migration and proliferation of keratinocytes and fibroblasts,
and ECM-induced contraction of fibroblasts contribute to
wound closure. We observed that elastic fibers were not
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Figure 3. Effects of fibulin-5 on proliferation and migration of dermal cells. (a) Proliferation assays using wild-type and fbln5/ skin fibroblasts measured after
24 hours of serum starvation followed by 24 hours of stimulation with EGF (10 ng/ml). Data are indicated as percentage relative to cell numbers measured
without stimulation. Bars indicate means7SD. NS, not significant. (b) Scratch assays using wild-type and fbln5/ skin fibroblasts performed in serum-free
medium (control), or with EGF (10 ng/ml) or 20% FBS. No difference between the two genotypes was seen. (c) Intracellular signaling induced by EGF (10 ng/ml)
in wild-type and fbln5/ skin fibroblasts. Phospho-c-Jun N-terminal kinase and extracellular signal-regulated kinase1/2 were significantly increased in both
wild-type and fbln5/ cells. Phospho-FAK was increased in a lesser degree. No significant difference was seen between the genotypes. (d) Representative
photos of skin explants from wild-type (n¼4) and fbln5/ (n¼3) mice. Keratinocytes were stained with anti-cytokeratin (arrows). (e) Area of migrating
keratinocytes was measured using ImageJ software.
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Figure 4. Breaking strength of full-thickness incision wounds. Fourteen days
following full-thickness incision wounding, the wounded skin (d–f) and
uninjured contralateral skin (a–c) were harvested and subjected to breaking
testing. Breaking stress (a, d) and strain (b, e) at the breaking point were
measured. (c, f) Average skin thickness. Wild-type (n¼6) and fbln5/ mice
(n¼8) were examined. All graphs show means7SEM.
2710 Journal of Investigative Dermatology (2006), Volume 126
Q Zheng et al.
Fibulin-5 in Dermal Wound Healing
detected in the granulation tissue at 14 days post-wounding
in wild-type mice, and the comparable speed of wound
closure between wild-type and fbln5/ mice indicated that
elastic fibers were not required for early phases of wound
healing. Our results also demonstrated that the absence of
elastic fibers in neighboring tissues did not affect migration of
keratinocytes or dermal fibroblasts into the wound bed, nor
affected the formation of granulation tissue.
Elastic fibers play an important role in maintenance of the
skin integrity. The fibers are organized in an elaborate three-
dimensional network in the dermis where they provide
elasticity and recoil. In an early study, granulation tissue was
found to be devoid of elastin staining and thus elastic fibers
were thought not to be actively involved in the wound
healing process (Montagna et al., 1988). Another study,
however, showed that elastin and fibrillin-1 were deposited
in the deep wound bed 7 days post-injury and expression
persisted for 21 days (Ashcroft et al., 1997). In a keratinocyte
autograft model, elastin deposition was shown to appear first
at the dermo-epidermal junction preceding elastic fiber
formation (Raghunath et al., 1996). Overall, our in vivo
findings together with previous reports confirmed that elastic
fibers do not participate in the wound closure process itself,
rather they may play a supportive role in re-establishment of
dermal architecture.
Role of fibulin-5 during wound healing
Although production and deposition of fibulin-5 was
significantly upregulated in the granulation tissue before the
formation of elastic fibers, we did not detect any differences
in breaking strength between the wild-type and fbln5/ skin.
Breaking stress and strain are affected by various factors, most
notably by collagen fibers. Inactivation of genes involved in
collagen assembly or maintenance, including decorin,
dermatopontin, and thrombospondin 2, is known to exhibit
reduced tensile strength (Danielson et al., 1997; Kyriakides
et al., 1998; Takeda et al., 2002). Our observation that
collagen fibers are not morphologically affected by the
absence of fibulin-5 (J. Choi et al., unpublished observation),
together with our previous finding that fibulin-5 did not bind
type I collagen in vitro (Yanagisawa et al., 2002), suggests
that fibulin-5 is not involved in collagen assembly or
collagen–matrix interactions.
In a previous study, retrovirus-mediated gene transduction
of fbln5 in a full-thickness wound was reported to simulate
granulation formation and facilitated wound closure in rabbit
ear (Lee et al., 2004). Increased production of type I collagen
by fibulin-5 was suggested to be a part of the mechanism for
the accelerated wound closure. In contrast, our loss-of-
function study does not support this notion; however, it is
plausible that a net change in the amount of ECM may have
affected the outcome of ECM-mediated cell signaling.
Angiogenesis and fibulin-5
Fbln5/ skin showed an enhanced neovascularization
before and during wound healing compared to wild-type
skin. As we have not observed increased vessel formation or
altered vascular patterning during embryonic development
(H Yanagisawa, unpublished observation), the absence of
fibulin-5 may just result in a more permissive environment for
angiogenesis during postnatal development. Consistent with
this notion, we see a general increase in small cutaneous
vessels in fbln5/ skin in older animals (Sullivan et al.,
manuscript in preparation).
It has recently been shown that sprouting endothelial cells
and pericytes use elastic fibers as a scaffold for migration in
rat mesenteric connective tissues (Anderson et al., 2004).
Although the dependence on elastic fibers as tracks for
sprouting is reduced during physiological wound healing or
after chemical induced angiogenesis, over 60% of sprouts are
still in direct contact with elastic fibers during these
processes. Thus, it is possible that fibulin-5-containing fibers
may also serve as a track for invading small vessels.
Consistent with this notion, fibulin-5 has been shown to
form fibers by binding to pre-existing matrices (Zheng et al.,
manuscript in preparation), and the binding partners are not
limited to elastin (Freeman et al., 2005).
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Figure 5. Increased blood vessel formation during wound healing in
fbln5/ mice. (a–d) CD31 immunostaining in the skin of wild-type (a, b) and
fbln5/ (c, d) mice before (a, c) and 14 days post-wounding (b, d). Sections
are counterstained with methyl green. Tortuous vessels are observed in the
fbln5/ skin even before wounding (c, arrows). The number of vessels
increased in the fbln5/ skin (d, arrows) compared to wild type (b, arrows)
after wounding. Bar¼ 200mm. (e) Quantification of dermal vessels in
wild-type and fbln5/ skin before and 14 days post-wounding. A minimum
of four images of non-injured dermis and granulation tissues were captured
from each section and vessels were counted. Four sections per animal
were quantified from four animals per genotype. Bars indicate
means7SD. *Po0.05.
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Of interest is the fact that increased neovascularization in
fbln5/ mice did not facilitate wound healing. A strong
relationship between angiogenesis and wound healing has
been reported for mice deficient for endothelial nitric oxide
synthase, syndecan-4, and thrombospondin 2 (Kyriakides
et al., 1999; Lee et al., 1999; Echtermeyer et al., 2001). In
addition, therapeutic strategies to facilitate angiogenesis
during wound healing have been considered using thymosin
4, vascular endothelial growth factor, and FGF ligands
(Malinda et al., 1999; Simons, 2005). Our current study
offers an interesting example where increased angiogenesis
does not promote more rapid wound healing. However,
vascularization may be critical for more complex wound
healing processes such as with an underlying diabetic
condition (Galiano et al., 2004). Further analysis of the direct
role of fibulin-5 on endothelial function will be necessary to
establish a molecular basis of the role of fibulin-5 in
angiogenesis.
MATERIALS AND METHODS
Mice
Fbln5/ mice were maintained on a C57BL6 129/SvEv hybrid
background and kept under a 12-hours/12-hours light cycle in
specific pathogen-free condition (Yanagisawa et al., 2002). Wild-
type or heterozygous littermates were used as controls. All animal
experimental procedures were reviewed and approved by the
Institutional Animal Care and Use Committees at the University of
Texas Southwestern Medical Center.
Reverse transcriptase-polymerase chain reaction
Total RNA was isolated from dorsal skin before and after wounding
using Trizol reagent (Invitrogen, Grand Island, NY) according to the
manufacturer’s protocol. RNA was treated with DNase I (RNase free,
Ambion, Austin, TX), followed by first-strand synthesis using randam
hexamer primers (Bio-Rad, Hercules, CA) from 1mg of total RNA.
PCR was performed with 2 ml of the cDNA for 30 cycles (30 seconds
at 941C, 30 seconds at 551C, and 30 seconds at 721C) for
amplification of fbln5 and G3PDH. Sequences of primers are
available upon request.
Histology
Hematoxylin and eosin staining was used for routine histological
observations. Modified Hart’s and Masson-Trichrome staining were
used for visualization of elastic fibers and collagen fibers,
respectively.
Skin explants culture
The medium was prepared as described previously (Mazzalupo
et al., 2002) with modifications. DMEM was mixed with Ham’s F-12
medium (Invitrogen) in a 3:1 ratio and supplemented with EGF
(10 ng/ml; Roche, Germany), cholera toxin (0.1 nM), T3 (2 nM),
transferrin (5mg/ml), insulin (5 mg/ml), hydrocortisone (0.4 mg/ml)
(all from Sigma, St Louis, MO), penicillin (100 U/ml), streptomycin
(100mg/ml) (Invitrogen), and 10% FBS (Gemini, Woodland, CA).
Postnatal day (P) 2 wild-type and fbln5/ pups were killed and the
whole dorsal skin was harvested. Two 8 mm sterile punches were
made from each pup and laid flat individually into a 12-well tissue
culture dish, dermis side down. Explants were incubated at 371C for
5 minutes to let skin adhere. Four hundred microliters of medium
was added into each well. The explants were submerged by adding
1.5 ml/well medium on the following day. Keratinocytes were
stained with anti-cytokeratin (Biolegend, San Diego, CA) at 1:50
dilution, followed by biotinylated goat anti-mouse 1:200 and
diaminobenzidine substrate. Total area of migrated keratinocytes
was measured and quantified by image J image analysis software
(NIH).
Immunohistochemistry
Skin tissue was immersion fixed in 4% paraformaldehyde overnight
at 41C for fibulin-5 and elastin staining, and in zinc fixative solution
(Beckstead, 1994) for 24 hours at room temperature for CD31 and
a-smooth muscle actin staining. Sections (10mm) were deparaffi-
nized and rehydrated in alcohol gradients. After rinsing with
phosphate-buffered saline, sections were treated with 1% H2O2 for
10 minutes at room temperature and blocked in 3% BSA and 1%
normal goat serum. Primary antibodies for fibulin-5, raised against
recombinant full-length rat fibulin-5, and for elastin (provided by Dr
Robert Mecham, Washington University School of Medicine) were
diluted 1:200, anti-CD31 (BD Biosciences Pharmingen, San Diego,
CA) was diluted 1:50, and anti-a-smooth muscle actin (Sigma) was
diluted 1:500 in blocking solution and incubated at 41C overnight.
Slides were washed 3 10 minutes with phosphate-buffered saline
and incubated with biotinylated anti-rabbit (fibulin-5 and elastin),
anti-rat (CD31), or anti-mouse (a-smooth muscle actin) secondary
antibodies (1:200; Vector Labs, Burlingame, CA) for 1 hour at room
temperature. Slides were washed as described above. Streptavidin-
conjugated horseradish peroxidase and diaminobenzidine substrate
were used as directed by the manufacturer (ABC and DAB Kit,
Vector Labs, Burlingame, CA).
Cells
Primary skin fibroblasts were prepared from the dorsal skin of P1
wild-type and fbln5/ pups as described previously (Yanagisawa
et al., 2002). Cells were cultured in DMEM containing 10% FBS,
streptomycin (100 mg/ml), and penicillin-G (100 U/ml).
In vitro proliferation assays
Wild-type and fbln5 / skin fibroblasts were plated in 96-well
dishes (2,000 cells/well) and serum-starved for 24 hours to synchro-
nize the cell cycle and then stimulated with EGF (10 ng/ml). Cell
numbers were quantified using Cell Titer 96 Aqueous One Solution
(Promega, Madison, WI) according to the manufacturer’s instruc-
tions. Three independent experiments were performed in duplicate
and the results were presented as the fold-increase over non-
stimulated wild-type cells at 24 hours to allow for comparison
between experiments.
In vitro scratch assays
Wild-type and fbln5 / skin fibroblasts were plated at approxi-
mately 80% confluency in six-well dishes. Cells were allowed to
reach confluence and serum-starved for 24 hours. A sterile 1 ml
pipette tip was used to administer the scratch injury. Media were
changed to DMEM containing no additives, 10 ng/ml EGF, or 20%
FBS. Cells were allowed to migrate into the cleared zone for 24 hours
and fixed in 4% paraformaldehyde. Images were captured and cells
were scored based on the distance migrated from the border of the
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scratch injury. Two independent experiments were performed in
duplicate for skin fibroblasts. Four to five separate images were
scored for each condition.
In vivo wound healing assays
Excision wound healing experiments were performed as previously
described with some modifications (Crowe et al., 2000). Briefly,
8–12-week-old wild-type and fbln5/ mice were anesthesized and
two full-thickness skin punch biopsies of 0.8 cm were created using
a disposable dermal biopsy punch (Miltex, York, PA). Wounds were
covered with a semipermeable polyurethane nonabsorbent dressing
(OpSite, Smith & Nephew, Largo, FL) and sealed at the edge. Skin
wounds were documented on postoperative day 0, 1, 3, 5, 7, 10, and
14 using a digital camera and the wound area was measured using
Image J software (NIH).
Tensile strength
Wild-type and fbln5/ male mice (12- to 20-week-old)
were anesthetized and one full-thickness incision (2.0 cm) was
created parallel to the spinal column and the wound was staple-
closed and allowed to heal for 14 days. Dorsal skin from the
wounded and contralateral sides were harvested and trimmed into
an ASTM standard dog-bone shape for tensile testing. The thickness
of the samples was taken at four random locations using a constant
force thickness indicator (Mitutoyo, Litematic VL-50A,
70.0 001 mm) and recorded. The sample dimensions were verified
using a handheld digital micrometer (Mitutoyo, Series 500,
70.01 mm). The breaking stress and breaking strain were deter-
mined from the engineering stress–strain curve acquired with an
EnduraTEC ELectroForces 3200 soft tissue tester (Bose Corporation,
Eden Prairie, Minnesota). Briefly, samples were fastened between
two clamps with 12 mm gauge length (the distance between the
clamps) and longitudinally stretched along their length under
displacement control at a constant strain rate of 0.1 mm/second.
Time, force, and displacement were recorded for stretching to
failure.
Statistical analysis
Statistical analysis between genotypes was performed by unpaired
Student’s t-test. P-value less than 0.05 was considered statistically
significant.
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